Kavita Vermani

This inventor holds 6 USPTO granted patents and 20 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Adamas Pharma, LLC, Adamas Pharmaceuticals, Inc.. Active years: 2014-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kavita Vermani. Retrieved from https://idiyas.com/inventor/kavita-vermani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 20)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 90(Granted Patents)

Company Filing History:

Adamas Pharmaceuticals, Inc.

patents

Years Active: 2014-2021

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11197835 - Method of administering amantadine prior to a sleep period (2021-12-14),

2. 9877933 - Method of administering amantadine prior to a sleep period (2018-01-30),

3. 9867793 - Method of administering amantadine prior to a sleep period (2018-01-16),

4. 9867792 - Method of administering amantadine prior to a sleep period (2018-01-16),

5. 9867791 - Method of administering amantadine prior to a sleep period (2018-01-16),

6. 8741343 - Method of administering amantadine prior to a sleep period (2014-06-03),

Title: Kavita Vermani: Innovator in Sleep Medicine

Introduction

Kavita Vermani is a prominent inventor based in Fremont, CA, known for her significant contributions to the field of sleep medicine. With a total of six patents to her name, she has focused on developing methods to improve patient care during sleep disturbances.

Latest Patents

Among her latest patents is a method of administering amantadine prior to a sleep period. This innovative approach describes methods of nighttime administration of amantadine to reduce sleep disturbances in patients undergoing treatment with the drug. Additionally, she has developed compositions of extended-release amantadine that are suitable for nighttime administration, further enhancing the therapeutic options available for patients.

Career Highlights

Kavita has worked with notable companies in the pharmaceutical industry, including Adamas Pharma, LLC and Adamas Pharmaceuticals, Inc. Her work has been instrumental in advancing treatments that address sleep-related issues, showcasing her dedication to improving patient outcomes.

Collaborations

Throughout her career, Kavita has collaborated with esteemed colleagues such as Gregory T Went and Gayatri Sathyan, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Kavita Vermani's work in sleep medicine exemplifies the impact of innovative thinking in healthcare. Her patents and collaborations reflect her commitment to enhancing the quality of life for patients experiencing sleep disturbances.

Profile summary based on public USPTO records.